Scientists develop a polymer for effective vascular filling.
Russian scientists from the Novosibirsk Institute of Organic Chemistry have created an embolic agent—a polymer designed to fill pathological vascular formations and prevent their rupture. This domestic product stands out from imported counterparts due to its purer composition and lower cost.
In collaboration with surgeons from the National Medical Research Center and the company “Medin,” scientists are testing the final version of the embolic agent in the laboratory of experimental surgery and morphology at the Institute of Experimental Biology and Medicine of the NRC. The production of the drug is scheduled to begin in 2025. This will help timely compensate for the shortage of imported analogs in the Russian market caused by sanctions.
The embolic agent can be used to fill vessels with deposits of cholesterol plaques, preventing a slowdown in blood flow and reducing the risk of vessel blockage. The embolization technology allows for the closure of blood supply to dangerous vessels, stopping the blood supply to affected organs and tissues. This can be beneficial, for example, in stopping the blood supply to tumors.
Photo: freepik